Madeline L O'Sullivan1, Rebecca A Shelby1, Caroline S Dorfman1, Sarah A Kelleher1, Hannah M Fisher2, Krista A Rowe Nichols3, Francis J Keefe1, Anthony D Sung3, Tamara J Somers4. 1. Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, 2200 W. Main St., Suite 340, Durham, NC, 27705, USA. 2. Department of Psychology, University of Miami, 5665 Ponce De Leon Blvd, Coral Gables, FL, USA. 3. Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, 2400 Pratt St., Suite 9000, Durham, NC, 27710, USA. 4. Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, 2200 W. Main St., Suite 340, Durham, NC, 27705, USA. tamara.somers@duke.edu.
Abstract
PURPOSE: Pain is common for hematopoietic stem cell transplant (HSCT) patients and may be experienced pre-transplant, acutely post-transplant, and for months or years following transplant. HSCT patients with persistent pain may be at risk for poor quality of life following transplant; however, the impact of pre-transplant pain on quality of life post-transplant is not well understood. Self-efficacy for chronic disease management is associated with quality of life among cancer patients and may impact quality of life for HSCT patients. The primary aim was to examine the effect of pre-transplant pain and self-efficacy on quality of life domains in the year following transplant. METHODS: One hundred sixty-six HSCT patients completed questionnaires providing information on pain, self-efficacy, and quality of life prior to transplant, at discharge, and 3-, 6-, and 12-months post-transplant as part of a longitudinal, observational study. Linear mixed modeling examined the trajectories of these variables and the effect of pre-transplant pain and self-efficacy on post-transplant quality of life. RESULTS: Pain and social and emotional quality of life remained stable in the year following transplant while self-efficacy and physical and functional quality of life improved. Pre-transplant pain was significantly related to lower physical well-being post-transplant. Lower pre-transplant self-efficacy was related to lower quality of life across all domains post-transplant. CONCLUSION: Above and beyond the effect of pre-transplant pain, self-efficacy for managing chronic disease is important in understanding quality of life following transplant. Identifying patients with pain and/or low self-efficacy pre-transplant may allow for early intervention with self-management strategies.
PURPOSE: Pain is common for hematopoietic stem cell transplant (HSCT) patients and may be experienced pre-transplant, acutely post-transplant, and for months or years following transplant. HSCT patients with persistent pain may be at risk for poor quality of life following transplant; however, the impact of pre-transplant pain on quality of life post-transplant is not well understood. Self-efficacy for chronic disease management is associated with quality of life among cancer patients and may impact quality of life for HSCT patients. The primary aim was to examine the effect of pre-transplant pain and self-efficacy on quality of life domains in the year following transplant. METHODS: One hundred sixty-six HSCT patients completed questionnaires providing information on pain, self-efficacy, and quality of life prior to transplant, at discharge, and 3-, 6-, and 12-months post-transplant as part of a longitudinal, observational study. Linear mixed modeling examined the trajectories of these variables and the effect of pre-transplant pain and self-efficacy on post-transplant quality of life. RESULTS: Pain and social and emotional quality of life remained stable in the year following transplant while self-efficacy and physical and functional quality of life improved. Pre-transplant pain was significantly related to lower physical well-being post-transplant. Lower pre-transplant self-efficacy was related to lower quality of life across all domains post-transplant. CONCLUSION: Above and beyond the effect of pre-transplant pain, self-efficacy for managing chronic disease is important in understanding quality of life following transplant. Identifying patients with pain and/or low self-efficacy pre-transplant may allow for early intervention with self-management strategies.
Entities:
Keywords:
HSCT; Pain; Quality of life; Self-efficacy
Authors: Allen C Sherman; Stephanie Simonton; Umaira Latif; Thomas G Plante; Elias J Anaissie Journal: Biol Blood Marrow Transplant Date: 2009-01 Impact factor: 5.742
Authors: Nicole Hochhausen; Elizabeth M Altmaier; Richard McQuellon; Stella M Davies; Esperanza Papadopolous; Shelly Carter; Jean Henslee-Downey Journal: J Psychosoc Oncol Date: 2007
Authors: P Niscola; C Romani; L Scaramucci; T Dentamaro; L Cupelli; A Tendas; D Piccioni; M Giovannini; B Tolu; C Cartoni; E Arcuri; A Perrotti; R Palumbo; P de Fabritiis Journal: Bone Marrow Transplant Date: 2008-02-04 Impact factor: 5.483
Authors: Anthony D Sung; Vinay K Giri; Helen Tang; Krista Rowe Nichols; Meagan V Lew; Lauren Bohannon; Yi Ren; Sin-Ho Jung; Tara Dalton; Amy Bush; Jolien Van Opstal; Alexandra Artica; Julia Messina; Rebecca Shelby; Jennifer Frith; Martha Lassiter; Jill Burleson; Kari Leonard; Ashley S Potter; Taewoong Choi; Cristina J Gasparetto; Mitchell E Horwitz; Gwynn D Long; Richard D Lopez; Stefanie Sarantopoulos; Nelson J Chao Journal: Transplant Cell Ther Date: 2022-01-20
Authors: Sam H Ahmedzai; John A Snowden; Andrew John Ashcroft; David Allan Cairns; Cathy Williams; Anna Hockaday; Jamie D Cavenagh; Debo Ademokun; Eleni Tholouli; David Allotey; Vijay Dhanapal; Matthew Jenner; Kwee Yong; Jim Cavet; Hannah Hunter; Jennifer M Bird; Guy Pratt; Christopher Parrish; Julia M Brown; Treen C M Morris; Gordon Cook Journal: J Clin Oncol Date: 2019-04-10 Impact factor: 44.544
Authors: Jennifer C Plumb Vilardaga; Sarah A Kelleher; Allison Diachina; Jennie Riley; Tamara J Somers Journal: Pilot Feasibility Stud Date: 2022-08-01